Premium
Somerset Indus Capital Partners, a healthcare-focused private equity firm, has closed its fifth investment from its second fund with a minority stake in a pharma contract development and manufacturing organisation. The PE firm, which counts companies such as Krsnaa Diagnostics, Hexagon Nutrition and Sterling Hospitals in its portfolio, has invested Rs 150 ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
